Daily treatments with specific bacterial strains in different animal models of T2DM have been shown to attenuate symptoms of diabetes, including postprandial blood glucose and insulin resistance via an increase of intestinal GLP-1 levels (43, 44). Here, GCG is linked to type 2 diabetes mellitus.